Entering text into the input field will update the search result below

Knight Therapeutics reports Q3 results

  • Knight Therapeutics (OTC:KHTRF): Q3 GAAP EPS of -C$0.021.
  • Revenue of C$4.03M (+25.2% Y/Y)
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
KHTRF
--
GUD:CA
--